Altamira Therapeutics Ltd. (CYTOF): 6-K filed Dec 20, 2024

Form type

6-K

Filing date

Dec 20, 2024

Accession number

0001213900-24-110771

Filer

Altamira Therapeutics Ltd. (CIK 1601936)